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The APC Tumor Suppressor Binds
to C-Terminal Binding Protein
to Divert Nuclear -Catenin from TCF
embryonic extracts of Drosophila, we identified Dro-
sophila C-terminal binding protein (dCtBP). This protein
and its mammalian homologs CtBP1 and CtBP2 are
transcriptional corepressors that bind to a number of
diverse DNA binding proteins including, apparently,
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some of the TCF factors (Chinnadurai, 2002). We show
specific binding between APC and CtBP in vitro and
specific association of these proteins in colorectal can-
Summary
cer cells, and we provide evidence for the functional
relevance of this interaction in TCF-mediated transcrip-
Adenomatous polyposis coli (APC) is an important tu-
tion. In contrast, the in vitro binding between CtBP and
mor suppressor in the colon. APC antagonizes the TCF is very weak, and the two proteins are neither de-
transcriptional activity of the Wnt effector -catenin tectably associated in mammalian cells nor show any
by promoting its nuclear export and its proteasomal direct functional interaction with each other. Our results
destruction in the cytoplasm. Here, we show that a thus question the previously proposed role of CtBP as
third function of APC in antagonizing -catenin in- a direct corepressor of TCF. Rather, they suggest that
volves C-terminal binding protein (CtBP). APC is asso- CtBP sequesters nuclear APC/-catenin complexes and
ciated with CtBP in vivo and binds to CtBP in vitro antagonizes TCF-mediated transcription by lowering the
through its conserved 15 amino acid repeats. Failure of availability of free -catenin for binding to TCF.
this association results in elevated levels of-catenin/
TCF complexes and of TCF-mediated transcription. Results and Discussion
Notably, CtBP is neither associated with TCF in vivo
nor does mutation of the CtBP binding motifs in TCF-4 CtBP Binds to APC In Vivo and In Vitro
alter its transcriptional activity. This questions the idea To identify proteins that bind to APC in Drosophila em-
that CtBP is a direct corepressor of TCF. Our evidence bryos, we incubated crude embryonic extracts with bac-
indicates that APC is an adaptor between -catenin terially expressed Drosophila E-APC (Yu et al., 1999)
and CtBP and that CtBP lowers the availability of free fused to glutathione-S-transferase (GST). Analysis of as-
nuclear -catenin for binding to TCF by sequestering sociated proteins by MALDI mass spectrometry revealed
APC/-catenin complexes. dCtBP as an unexpected binding partner of E-APC. CtBP
was initially discovered as a cellular protein binding to
the C terminus of the adenovirus E1A protein, whichIntroduction
suppresses its transformation potential (Boyd et al.,
1993). CtBP is a transcriptional corepressor in mammalsMost colorectal tumors have inactivating mutations in
(Chinnadurai, 2002; Sollerbrant et al., 1996) and Dro-APC, and APC loss is an early if not initiating event in
sophila (Nibu et al., 1998a, 1998b; Poortinga et al., 1998)colorectal tumorigenesis (Kinzler and Vogelstein, 1996).
and binds to various DNA binding proteins via a shortAlmost all mutations produce APC truncations, and the
conserved motif P-h-D-L-S-x-R/K (Schaeper et al.,majority of these terminate within or upstream of the
1995). Mammals have a second CtBP relative, CtBP2,mutation cluster region (MCR) in the middle of the coding
which also recognizes this motif (Turner and Crossley,region (Nagase and Nakamura, 1993). The main function
1998) and whose function overlaps that of CtBP (Hilde-of APC is to downregulate the transcriptional activity of
brand and Soriano, 2002).-catenin, a Wnt effector that binds to DNA binding
Intriguingly, a motif similar to P-h-D-L-S-x-R/K is foundproteins of the T cell factor (TCF) family to stimulate the
in each of the 15 amino acid repeats (15R) of APC and oftranscription of Wnt target genes (Polakis, 2000). This
Drosophila E-APC (Figure 1A). These repeats can bind tofunction of APC appears to be critical in the suppression
-catenin but cannot promote its proteasomal destructionof colorectal tumorigenesis (van de Wetering et al., 2002).
(Rubinfeld et al., 1997), as the latter requires the AxinAPC downregulates the transcriptional activity of
binding motifs of APC (e.g., von Kries et al., 2000). There-
-catenin in three ways (Bienz, 2002). Its best-estab-
fore, there is no known function of the 15Rs in the down-
lished function is to reduce the levels of cytoplasmic
regulation of -catenin. The interaction between an indi-
-catenin by binding to Axin, which results in the phos-
vidual 15R and -catenin has been characterized at the
phorylation of -catenin and its subsequent proteaso- structural level (Eklof Spink et al., 2001). The presumed
mal destruction. Furthermore, APC also promotes the CtBP binding motif shares some but not all of the resi-
export of nuclear -catenin (Henderson, 2000; Neufeld dues in the C-terminal half of the 15R that are engaged
et al., 2000; Rosin-Arbesfeld et al., 2000). Finally, there in the interaction with -catenin (Figure 1A).
are indications that APC can sequester -catenin, thus Binding between E-APC and dCtBP was confirmed
keeping it from binding to TCF and activating transcrip- in vitro by pull-down assays between bacterially ex-
tion (Neufeld et al., 2000; Rosin-Arbesfeld et al., 2003). pressed GST-dCtBP and in vitro translated E-APC (Fig-
In a search for additional APC-associated proteins in ure 1B). This binding is comparable to that between E-APC
and Armadillo (Drosophila -catenin) (Figure 1B); how-
ever, Armadillo does not bind directly to GST-dCtBP*Correspondence: mb2@mrc-lmb.cam.ac.uk
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Figure 1. Direct Binding between CtBP and APC
(A) Top: CtBP binding sites within the 15Rs of APC and E-APC (dots indicate residues in 15R-1 engaged in direct contact with -catenin).
AxAxA has triple alanine substitutions in residues 1, 3, and 5 of the P-h-D-L-S-x-R/K motif (h, hydrophobic) of each 15R; AxAxAplus has
further triple substitutions in two putative additional motifs (PADLAHK at codon 1001, PSDLPDS at codon 1420 of APC). Bottom: Structures
of APC and E-APC, with conserved sequences boxed (ARD, gray; 15Rs, black; 20Rs, white; Axin binding sites, stippled; MCR, mutation cluster
region; arrowheads point to putative additional CtBP binding sites in APC); binding activities of minimal wild-type and mutant fragments are
summarized below.
(B–F) Pull-down assays between bacterially expressed GST-fusions and in vitro translated protein, as indicated; (B–E) total reactions were
loaded in lanes denoted “input;” (F) 2% of each input protein is shown in the top panel; below, total reactions were loaded in each lane (long
exposures of the same gels are shown on the right).
(G) Western blots of wild-type and mutant versions of GFP-APC(918–1698) or of GFP alone (top) after cotransfection with HA--catenin
(bottom); in each case, 200 ng of plasmid was used.
(Figure 1E). A small region spanning the two 15Rs of levels of coexpressed HA-tagged -catenin in trans-
fected APC mutant cancer cells (Figure 1G), though aE-APC fused to GST is sufficient for binding to in vitro
translated dCtBP (Figure 1C), while a triple alanine sub- low level of endogenous -catenin can still be detected
by immunofluoresence in these transfected cells (Figurestitution (“AxAxA”) in the P-h-D-L-S motif of each 15R
(in the context of the C-terminal half of E-APC) almost 3D). Thus, the binding between APC and CtBP is specific
and conserved and neither appears to affect APC’s bind-completely abolishes binding to dCtBP (Figure 1D). The
same is true for the binding between human CtBP and ing to -catenin nor its ability to promote the destruction
of cytoplasmic -catenin.a central fragment of APC (residues 918–1698) that binds
efficiently to GST-CtBP, while its mutant version AxAxA APC is also associated with CtBP in mammalian cells:
endogenous CtBP can be coimmunoprecipitated withbinds poorly (Figure 1F). APC(918–1698) contains two
further putative CtBP binding motifs that were substi- endogenous APC, and vice versa, in 293T cells (Figure
2A) and in HCT116 colorectal cancer cells that expresstuted in addition (“AxAxAplus”; Figure 1A). This further
reduced the binding to GST-CtBP (by16%); no binding wild-type APC (Figure 2B). Furthermore, in APC mutant
cancer cells, the resident APC truncations can be coim-whatsoever was detectable with a GST-LEF-1 control
(Figure 1F). Importantly, both APC mutants bind to munoprecipitated in SW480 cells, but not in COLO320
cells (Figures 2B and 2C). Notably, the 15Rs are retained-catenin equally well as the wild-type (Figure 1F). Like-
wise, both mutants retain the ability to reduce the overall only in the APC truncation of the former, but not of the
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Figure 2. Association between APC and CtBP in Mammalian Cells
(A–C) Coimmunoprecipitations between endogenous CtBP and APC in various cell lines, as indicated (IP, immunoprecipitation; IB, immunoblot-
ting; names of antibodies are given in brackets); in lanes denoted “lysate,” 3% of the total sample were loaded. Relevant bands are indicated
by arrowheads (arrows in [B] and [C] point to a background band due to Ab-1, particularly prominent in COLO320 extracts). APC was also
coimmunoprecipitated successfully with anti-CtBP E-12 antibody (not shown).
(D) Summary of the in vivo associations between CtBP and APC in human cells expressing wild-type APC (293T, HCT116) or APC truncations
(SW480, COLO320).
latter (Figure 2D). Thus, the association of APC with substantially (Figure 3A) after cotransfection with
APC(918–1698), which spans the 15Rs and the 5-mostCtBP in mammalian cells depends on its 15Rs.
nuclear export signal (NES1506) and Axin binding site
(Figure 1A). Similar APC fragments have previously beenMutant APC that Cannot Bind to CtBP Is Less
found to efficiently reduce the -catenin levels in SW480Active in Complementation Assays
cells (Munemitsu et al., 1995). In contrast, the AxAxAof Colorectal Cancer Cells
mutant is less active in reducing TOPFLASH values, andFew colorectal carcinomas express APC truncations
AxAxAplus is even less active (Figure 3A). The controlthat lack the 15Rs (e.g., Miyaki et al., 1994). COLO320
values of pFOPFLASH (containing mutant TCF sites;is one of the rare colorectal cancer cell line of this type
Korinek et al., 1997) are low and unchanged by the(Rowan et al., 2000). Interestingly, this line exhibits ex-
mutants (Figure 3A). We conclude that the binding be-ceptionally high TCF-mediated transcription (Rosin-
tween APC and CtBP is critical for the APC-mediatedArbesfeld et al., 2003). This suggests that the 15Rs may
downregulation of the transcriptional activity of -catenin.harbor an activity that is critical for the downregulation
The residual activities of AxAxA and AxAxAplus in thisof the transcriptional activity of TCF.
assay are likely to reflect their ability to promote Axin-To test whether the binding of CtBP to the 15Rs is
mediated destruction (Figure 1G) and nuclear export offunctionally relevant, we used a complementation assay
-catenin (see above; note that APC(918–1698) and itsof APC mutant cancer cells based on a luciferase re-
mutant versions shuttle in and out of the nucleus, asporter linked to TCF binding sites (pTOPFLASH; Korinek
judged by their nuclear accumulation after exposure toet al., 1997). This quantitative assay is highly specific
leptomycin B; Figure 3D).for TCF-mediated transcription and serves as a fairly
direct readout of exogenous APC function in restoring
low levels of TCF transcription. COLO320 cells show Evidence that CtBP Sequesters APC/-Catenin
Complexes and Diverts Free Nuclearvery high TOPFLASH values (Figure 3A), 2 higher
than those of SW480 cells and up to 5 higher than -Catenin away from TCF
Previous evidence indicated that APC can sequesterthose of other APC mutant colorectal cancer cells
(Rosin-Arbesfeld et al., 2003). These values are reduced nuclear -catenin and keep it from binding to TCF and
Developmental Cell
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Figure 3. Binding between APC and CtBP Is Required for Reduction of TCF-Mediated Transcription
(A and B) TOPFLASH assays, measuring complementation of COLO320 cells by wild-type and mutant GFP-APC(918–1698) with or without
NLS, as indicated; average relative luciferase values from 3–5 experiments are given (error bars indicate standard deviations; FOPFLASH
control values are given in [A]).
(C) Western blots of total cell extracts, after transfection with GFP or of GFP-APC(918–1698) plasmids, probed with anti-GFP (see also Figure
1G) or with anti--tubulin as internal control.
(D) COLO320 cells, transfected with wild-type and mutant GFP-APC(918–1698) plasmids as in (B) and stained as indicated. In the absence
of an NLS, these APC proteins are predominantly cytoplasmic, but low nuclear levels are also detected (arrows), which are significantly increased
after LMB treatment (inserts). Linkage to an NLS efficiently targets APC proteins and, consequently, -catenin to the nucleus (arrowheads).
(E) Right: Coimmunoprecipitation of endogenous -catenin with endogenous TCF-4 in COLO320 cells transfected with wild-type (left) or
AxAxAplus mutant NLS-APC(918–1698) (right) after cell sorting. Left: total protein levels in lysates. Quantitative analysis of three independent
experiments shows 1.5–2 higher levels of TCF-4 bound -catenin in the presence of the APC mutant compared to the wild-type.
(F) Top: Coimmunoprecipitation of endogenous -catenin with endogenous APC (left) or Flag-LEF-1 (right) in CtBP1/ CtBP2/ mutant mouse
cells or in parental control cells, showing 2–3 higher levels of LEF-1-associated -catenin in the mutants (quantitative measurements from
four independent experiments). The total levels of -catenin, APC, and of the APC bound -catenin are the same in the two cell lines.
activating transcription (Neufeld et al., 2000; Rosin- A possible model is that APC binds to free nuclear
Arbesfeld et al., 2003). This sequestration can be dem- -catenin in competition with TCF and targets -catenin
onstrated experimentally if an APC fragment is targeted to CtBP (by being an adaptor between these two pro-
to the nucleus by linkage to a nuclear localization signal teins), thus diverting -catenin away from TCF. CtBP,
(NLS): this causes a dramatic nuclear accumulation of being anchored at specific sites within the nucleus (Ka-
endogenous -catenin, but these high levels of nuclear gey et al., 2003; Lin et al., 2003), could act as a “sink”
-catenin are ineffective in stimulating TCF-mediated for APC/-catenin complexes, thus shifting the binding
transcription (Figure 3B; Rosin-Arbesfeld et al., 2003). equilibrium of -catenin yet further away from TCF.
This therefore provides an assay for measuring the se- Three lines of evidence support this model. First,
questration of nuclear -catenin by APC.
-catenin can be detected in a complex with CtBP in
We thus tested NLS-fusions of the AxAxA and AxAx- SW480, but not in COLO320 cells (Figure 2C), whose
Aplus mutants in this sequestration assay. Interestingly,
APC truncation can bind neither CtBP nor -catenin.
the mutant NLS-fusions are less active in reducing TOP-
Second, in COLO320 cells transfected with NLS-fusionsFLASH values than their wild-type controls (Figure 3B).
of APC, we estimate that the levels of endogenous TCF-These differences are significant since the expression
4/-catenin complexes are 1.5–2 higher in the caselevels of wild-type and mutant NLS-fusions are essen-
of AxAxAplus compared to the wild-type control (Figuretially the same (Figure 3C). Notably, the loss of function
3E). These increased levels of TCF-4/-catenin com-of the AxAxA and AxAxAplus mutants in reducing
plexes are likely to be the basis for the high TCF-medi--catenin activity is exacerbated in this sequestration
ated transcription in the complementation assays (Fig-assay where the levels of nuclear -catenin are high
ure 3B). Third, in CtBP mutant mouse cells (Hildebrand(Figure 3B). This suggests a role of the APC-CtBP inter-
action in sequestering nuclear -catenin. and Soriano, 2002) expressing tagged LEF-1, 2–3
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to antagonize TCF-mediated transcription in a relatively
specific way.
CtBP Interacts Neither Physically nor Functionally
with TCF in Mammalian Cells
It has been reported that Xenopus CtBP can bind to
XTcf-3 and antagonize the transcription of TCF target
genes in the early Xenopus embryo (Brannon et al.,
1999). These authors noted that TCF-3 and TCF-4 fac-
tors possess CtBP binding motifs and suggested that
CtBP may be a corepressor of these TCFs (Brannon et
al., 1999). Potentially, this could explain the increased
basal levels of TCF-mediated transcription in CtBP mu-
tant cells compared to their parental controls (Figure
4A, second and third columns). However, it is unlikely
to explain the increased levels of Lef-1-stimulated tran-
scription (Figure 4A, fourth columns), given that Lef-1
is a TCF factor that lacks CtBP binding motifs (Brannon
et al., 1999; Hovanes et al., 2000).
In vivo association between CtBP and TCF had never
been demonstrated, so we decided to examine this in
comparison to the in vivo association between CtBP
and APC (Figure 2). First, we asked whether endogenous
CtBP and TCF-4 coimmunoprecipitate in colorectal can-
cer cells, given that TCF-4 is expressed in these cells
(Korinek et al., 1997). -catenin coimmunoprecipitates
with TCF-4, as expected; however, CtBP is not detect-
able in the same TCF-4 immunoprecipitate (Figure 5A,
Figure 4. Loss of CtBP Increases the Activity of -Catenin or Arma- left panel, lane 4). Conversely, while APC coimmuno-
dillo precipitates with CtBP (see also Figures 2B and 2C),
(A) TOPFLASH assays in CtBP mutant or control cells, cotransfected TCF-4 does not (Figure 5A, left panel, lane 2; note that
with control GFP or with activated -catenin (S33A),  or  mouse the antibody used in this case would have also detected
Lef-1 (200 ng of each plasmid), as indicated (internal control pRL-
CtBP-associated TCF-3; see Experimental Procedures).CMV); control FOPFLASH values are also given.
Thus, endogenous CtBP is associated with APC, but(B–G) Fly eyes and wings, with genotypes as indicated. Heterozy-
not with TCF, in colorectal cancer cells. Notably, thegosity for dCtBP enhances the rough eye phenotype (D, compare
to C) due to activated Armadillo (F76), but suppresses the wing nick same is true in 293T cells in which TCF is transcription-
phenotype in the posterior margin (G, compare to F) due to Armadillo ally inactive: endogenous CtBP is associated with APC
depletion (En.Gal4 UAS.cad-I). and -catenin, but not with endogenous TCF-4 (Figure
5A, right panel, lane 4). We conclude that TCF is not
detectable in a complex with CtBP, regardless of cell
more endogenous -catenin can be coimmunoprecipi- type and transcriptional activity.
tated with LEF-1 than in the corresponding parental It was previously reported that exogenous TCF-4 can
control cells (heterozygous for both alleles) (Figure 3F, repress TOPFLASH transcription in transfected simian
right panels). The total levels of -catenin are the same COS cells (that lack E1A expression) in a CtBP-depen-
in the two cell lines, as are the amounts of APC bound dent manner, while a C-terminal truncation of TCF-4
-catenin (Figure 3F, left panels). The latter two lines of without the CtBP binding motifs (such as those arising
evidence indicate that CtBP reduces the availability of from frameshift mutations in TCF-4 in some microsatel-
-catenin for binding to TCF. lite-unstable colorectal carcinomas; Ruckert et al., 2002)
If so, absence of CtBP should result in elevated levels does not respond to overexpressed CtBP in this assay
of TCF-mediated transcription. Indeed, the basal TOP- (Valenta et al., 2003). We repeated these experiments
FLASH activity (due to endogenous TCF/-catenin) in by comparing the activities of mutant TCF-4, whose two
CtBP mutant cells is increased3.7 compared to their CtBP binding motifs were mutated in the same way as
control cells (Figure 4A). Furthermore, cotransfection of those of APC (TCF-4 AxAxA) and its wild-type control
activated -catenin (S33A mutant) and Lef-1 stimulate in TOPFLASH assays, and in their response to overex-
TOPFLASH activity to higher levels in CtBP mutant cells pressed CtBP. We confirmed that overexpressed TCF-4
compared to the control (Figure 4A). By comparison, can repress TOPFLASH transcription in a dose-depen-
we detect 2 differences in transcriptional activity dent manner in transfected SW480 and COS cells (Figure
between mutant and wild-type cells if FOPFLASH or an 5B, black bars; not shown). However, the AxAxA TCF-4
SV40-based control reporter (pRL-SV) are tested (Figure mutant was similarly inhibitory (Figure 5B, white bars),
4A). Indeed, the activity levels of the internal control despite being expressed at slightly higher levels than
renilla reporter (pRL-CMV) are the same in both cell lines wild-type TCF (especially at low doses of transfected
(not shown). Therefore, Lef-1-mediated transcription is plasmid; Figure 5C). Furthermore, the mutant was
more sensitive to CtBP loss than the transcription medi- equally responsive to coexpressed CtBP as the wild-
type TCF-4 (Figure 5D). Therefore, although the AxAxAated by other transcription factors. Thus, CtBP appears
Developmental Cell
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Figure 5. Lack of Physical or Functional Interactions between CtBP and TCF in Mammalian Cells
(A) Coimmunoprecipitations between endogenous CtBP and APC or TCF-4 and between endogenous TCF-4 and CtBP or -catenin, in SW480
(left) or 293T cells (right), as indicated (IP, immunoprecipitation; IB, immunoblotting; lane 1, 3% of the total sample were loaded; lane 3, IgG
was used for control immunoprecipitations). Note that TCF-4 fails to immunoprecipitate with CtBP, although APC (and -catenin) do so (see
also Figures 2B and 2C); conversely, CtBP (and APC) fail to immunoprecipitate with TCF-4, although -catenin does so.
(B) TOPFLASH assays in SW480 cells, transfected with control GFP (“0”) or with increasing amounts of TCF-4 or TCF-4 AxAxA (internal
controls pRL-CMV); control FOPFLASH values are given on the right.
(C) Expression levels of wild-type and mutant AxAxA TCF-4 at different plasmid doses.
(D) TOPFLASH assays in COS cells, as in (B), cotransfected with or without 150 ng of activated -catenin (	45--catenin), 450 ng of TCF-4
or TCF-4 AxAxA, and increasing amounts of GFP-CtBP as indicated. TCF-4 AxAxA is similarly active in repressing transcription (B) and
responds equally to coexpressed CtBP as wild-type TCF-4 (D), despite being expressed at slightly higher levels ([C]; note that the luciferase
values in [B] and [D] have not been corrected for TCF expression levels).
(E) Pull-down assays between bacterially expressed CtBP or -catenin and in vitro translated wild-type or AxAxA mutant TCF-4, as indicated;
7% of total reactions were loaded in lanes denoted “input.” A long exposure is shown at the bottom to visualize the weak binding between
CtBP and TCF-4.
mutation affects the activity of APC(918–1698) in TCF- In summary, we were unable to obtain any evidence
for a significant physical or functional interaction be-specific transcription assays (Figures 3A and 3B), the
same mutation in TCF-4 does not affect its activity in tween CtBP and TCF. Our results thus question the idea
that CtBP functions generally as a corepressor of TCFthese assays (Figures 5B and 5D). In agreement with
this, a comparable double mutation of the CtBP binding factors. We agree with Ruckert et al. (2002) who con-
cluded that the TCF-4 frameshift mutations observed inmotifs in XTcf-3 does not reduce its repressive potential
in Xenopus embryos (Brannon et al., 1999). Note that microsatellite-unstable colorectal carcinomas are pas-
senger mutations without any functional relevance forthis double mutation does reduce the in vitro binding
of XTcf-3 to CtBP (Brannon et al., 1999), and so does TCF-mediated transcription or tumorigenesis.
the AxAxA double mutant of TCF-4 (Figure 5E). However,
the in vitro binding between CtBP and TCF-4 is 10 Antagonism between CtBP and Activated
Armadillo during Developmentless strong than that between TCF-4 and -catenin (Fig-
ure 5E). Thus, the in vitro binding between CtBP and We asked whether dCtBP might antagonize Armadillo-
mediated transcription during Drosophila development.TCF, although apparently specific, is very weak indeed.
It may be spurious, given the lack of a detectable associ- However, this is not straightforward to test, since dCtBP
mutants show highly pleiotropic mutant phenotypes:ation between these proteins in vivo.
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Experimental Proceduresnull mutant embryos are grossly abnormal and do not
develop beyond early stages, due to failing interactions
Plasmids, Mutagenesis, and In Vitro Pull-Down Assaysbetween dCtBP and segmentation gene products (Nibu
Plasmids encoding Drosophila E-APC(453–1067) and dCtBP have
et al., 1998a, 1998b; Poortinga et al., 1998). This precludes been described (Saller et al., 2002; Yu et al., 1999). Plasmids encod-
a meaningful analysis of dTCF target gene expression in ing human CtBP1, APC(918–1698), -catenin(134–671), TCF-4, and
these mutants (E. Saller and M.B., unpublished results). Drosophila Armadillo(156–690) and E-APC (2–455, 460–599, and
488–547) were generated by standard PCR cloning procedures andAnd although dCtBP has been implicated in antagoniz-
checked by sequencing; human CtBP1 was tagged with GFP bying dTCF transcription in the developing midgut, this is
subcloning into pEGFP-C2. Full-length human -catenin was taggedan indirect effect mediated by the DNA binding protein
at its N terminus with a triple HA tag and subcloned into pcDNA3.1
Brinker to which CtBP can bind (Saller et al., 2002). Like- (Invitrogen Life Technologies). Flag-tagged human LEF-1 (kindly
wise, CtBP loss in the mouse causes pleiotropic mutant provided by D. Ayer) was subcloned into the HpaI site of the pMIG
phenotypes, one of which—unexpectedly—mimics loss retroviral vector (Van Parijs et al., 1999). Myc-tagged human TCF-4
(in pcDNA1) (Korinek et al., 1997) was kindly provided by F. Townsley.of Wnt signaling (Hildebrand and Soriano, 2002), but
Triple alanine substitutions were introduced into fragments ofthis could also be an indirect effect of CtBP binding to
APC(918–1698) and E-APC(453–1067), and into TCF-4, by using aanother target protein outside the Wnt pathway.
site-directed mutagenesis kit (Stratagene); details of the primers areThus, to explore the regulatory relationship between
available on request.
dCtBP and Armadillo during development, we asked Wild-type and mutant APC(918–1698) were subcloned into
whether dCtBP loss would affect the phenotypic conse- pEGFP-C2 (CLONTECH Laboratories) and into pEGFP-C2NLS (be-
quences of overactive or depleted Armadillo. This is the tween EcoRI and BamHI), a vector containing an NLS from SV40
large T antigen (TPPKKKRKVED, between XhoI and EcoRI) (Rosin-case: lowering the dose of dCtBP enhances the rough
Arbesfeld et al., 2003), between their EcoRI and BamHI sites. Eacheye phenotype caused by activated Armadillo (Figures
NheI/BamHI fragment (including its N-terminal GFP tag), and also4B–4D; Freeman and Bienz, 2001), but the same condi-
full-length TCF-4, were subcloned into pBluescript II (between SpeI
tion suppresses the wing nick phenotype due to Arma- and BamHI) to generate 35S-labeled proteins by the coupled tran-
dillo depletion in cells whose stimulation by Wingless scription-translation TNT system (Promega).
is required for normal wing margin formation (Figures Human CtBP, -catenin, and LEF-1(1–110) and Drosophila Arma-
dillo and E-APC fragments were also subcloned into pGEX-2T or4E–4G; Sanson et al., 1996). These genetic interactions
pGEX-4T1 (Amersham Pharmacia Biotech). Recombinant GST-are similar to those of negative components of the Wnt
tagged proteins were expressed in Escherichia coli BL21 and puri-pathway that downregulate Armadillo, such as Drosoph-
fied by glutathione-Sepharose (Amersham Pharmacia Biotech).ila Axin and APC (Freeman and Bienz, 2001), consistent
In vitro pull-down assays were performed as described (Hamada et
with dCtBP antagonizing Armadillo. Again, we empha- al., 1999); same amounts of GST-fusions were used, as confirmed
size that this antagonism is unlikely to be due to dCtBP by Coomassie blue staining. Quantitative analysis was done with a
being a direct corepressor of dTCF, given that the latter Personal Densitometer SI (Molecular Dynamics); in Figure 1F, input
protein values (top) were taken into account, but background valuesdoes not contain any CtBP binding motifs (Brannon et
were not subtracted, given the low signals of the GST-CtBP boundal., 1999). Our results suggest that the antagonism be-
APC mutants.tween CtBP and Armadillo/-catenin is conserved and
operates in multiple tissues and cell types.
Identification of E-APC Binding Proteins
Cytoplasmic extracts of dechorionated Drosophila embryos (0–12
Conclusions hr), generated as described previously (Soeller et al., 1988), were
We presented evidence that CtBP binds to APC directly kindly provided by C.P. Verrijzer (Leiden University Medical Center).
and specifically via the conserved 15Rs of APC and that Isolation of E-APC binding proteins was performed essentially as
described (Soeller et al., 1988).the association of the two proteins in vivo is functionally
Molecular mass analyses of tryptic fragments were kindly per-relevant as it is required for the full activity of APC in
formed by S. Peak-Chew and F. Begum. Samples were analyzedreducing TCF-mediated transcription in colorectal can-
with a Voyager-DE-STR matrix-assisted laser desorption/ionizationcer cells. In contrast, we failed to obtain any evidence
time-of-flight mass spectrometer (PerSeptive Biosystem). Proteins
for a direct physical or functional interaction between were obtained by database searches using peptide masses with
CtBP and TCF in mammalian cells, calling into question the Mascot program (http://www.matrixscience.com). Molecular
whether CtBP acts generally as a transcriptional core- weights of 13 tryptic peptides derived from a 40 kDa protein purified
specifically with GST-E-APC(453–1067), but not with GST or GST-pressor of TCF factors.
E-APC(2–455), coincided with peptides from dCtBP.Instead, our evidence suggests that CtBP antagonizes
TCF-mediated transcription by cooperating with APC to
Coimmunoprecipitations and Western Blottingsequester nuclear -catenin. This sequestration could
For coimmunoprecipitations, cells were pelleted and lysed in extrac-be a safeguard function of APC, operating in parallel to
tion buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 1 mM EDTA,(and to some extent redundantly with) its other functions
0.1% Triton X-100, Protease Inhibitor cocktail; Roche). Lysates were
in promoting nuclear export and degradation of -catenin. centrifuged at 15,000 rpm at 4
C for 20 min and the supernatants
We propose that APC sequesters -catenin by targeting were incubated with protein G-Agarose beads (Roche) for 1 hr at 4
C.
it to CtBP, thus lowering the pool of free nuclear -catenin The mixture was then centrifuged for 10 s at 15,000 rpm, and the
that is available for binding to TCF. The sequestration of supernatant was transferred to a fresh tube and incubated with the
appropriate antibody for 1 hr at 4
C. Protein G-Agarose was thenthe APC/-catenin complex by CtBP may be based on
added and incubated for 30 min at 4
C. The mixture was centrifugedspatial segregation within the nucleus (e.g., anchoring
for 10 s at 15,000 rpm, the supernatant was removed, and the precip-of the complex at specific subnuclear bodies; Kagey et
itate was washed 4 with 1 ml of extraction buffer. After boiling in
al., 2003; Lin et al., 2003). Whatever the precise mecha- SDS-sample buffer, the immunoprecipitated proteins were sepa-
nism, the observed functional cooperation between rated by SDS-PAGE and transferred to Immobilon-P (Millipore) and
CtBP and APC in colorectal cancer cells suggests a role immunoblotted with the appropriate antibodies followed by Pro-
toBlot II AP System (Promega) (Hamada and Bienz, 2002) or byof CtBP as a tumor suppressor in the colon.
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the enhanced chemiluminescence (ECL) Western blotting system mounted for spraying, without dehydration in ethanol), and wings
were mounted in Euparal for viewing under bright-field (Barker et(Amersham) (Rosin-Arbesfeld et al., 2003). Comparative quantitative
analysis by densitometry revealed that the values obtained for the al., 2001).
same samples subjected in parallel to the two different blotting
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